Key result
Higher serum 25(OH)D levels are linked to ~97% lower odds of PDA in preterm neonates.
Why the study?
Patent ductus arteriosus is prevalent in preterm infants and compromises cardiopulmonary function, motivating analysis of early postnatal serum 25-hydroxyvitamin D levels and clinical risk factors for PDA.
Does a higher early postnatal serum 25-hydroxyvitamin D level (>14.25 ng/mL) reduce the risk of patent ductus arteriosus in preterm infants?
Observational (n=429)
No
Does a higher early postnatal serum 25-hydroxyvitamin D level (>14.25 ng/mL) reduce the risk of patent ductus arteriosus in preterm infants?
Early postnatal vitamin D deficiency or insufficiency is highly prevalent in preterm neonates, and a serum 25(OH)D level >14.25 ng/mL is independently associated with a reduced risk of patent ductus arteriosus, whereas caesarean delivery and neonatal respiratory distress syndrome increase PDA risk.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; hypothesis-generating for vitamin D supplementation trials in preterm neonates.
Background & Objective: Patent ductus arteriosus (PDA) is prevalent among preterm infants and can affect heart and lung function, lower systemic blood pressure, and lead to various complications. In this study, we aimed to analyse early postnatal serum 25-hydroxyVitamin-D [25(OH)D] levels in preterm infants and to explore risk factors for PDA. Methodology: This retrospective study included clinical data from premature infants admitted to the neonatology department of our hospital between December 2021 to November 2023. The population was grouped by demographic and clinical characteristics and 25(OH)D levels were compared within each group. Logistic regression analysis was employed to identify the risk factors for PDA. Results: A total of 429 preterm infants were enrolled. Vitamin-D deficiency or insufficiency was prevalent among preterm infants. Preterm infants born in winter, by caesarean section, those undergoing tracheal intubation, and those with neonatal respiratory distress syndrome (NRDS) and PDA had significantly lower Vitamin-D levels. Multivariate logistic regression analysis identified caesarean delivery and NRDS as risk factors for PDA. However, higher Vitamin-D levels and greater gestational age were protective factors against PDA. Conclusion: Preterm infants frequently experience Vitamin-D deficiency or insufficiency. 25(OH)D levels, delivery methods, gestational age, and NRDS affect the occurrence of PDA.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) conducted an observational in Patent ductus arteriosus in preterm neonates (n=429). Serum 25-hydroxyvitamin D [25(OH)D] >14.25 ng/mL vs. Serum 25(OH)D <14.25 ng/mL was evaluated on Occurrence of patent ductus arteriosus (PDA) confirmed by echocardiography (OR 0.03, 95% CI 0.02 ~ 0.06, p=<.001). Serum 25(OH)D levels >14.25 ng/mL were independently protective against patent ductus arteriosus in preterm neonates compared to levels <14.25 ng/mL.
Synapse has enriched 10 related papers. Consider them for comparative context: